Navigation Links
VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
Date:7/10/2008

-- Top-Line Data Expected in the Third Quarter --

SAN FRANCISCO, July 10 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that it has completed the last patient visit in its carotid endarterectomy (CEA) study. The excised carotid plaque tissue will be analyzed to determine VIA-2291's effect on inflammation, and the company remains on track to report top-line data in the third quarter.

VIA-2291 is a potent small molecule drug that targets inflammation in the blood vessel wall, a primary disease process in atherosclerosis. It is being developed as a once-daily, oral drug to potentially decrease the risk of major adverse cardiac events associated with inflammation, including heart attack and stroke.

"Analyzing the carotid plaque collected in the CEA trial is a novel approach to aid investigators in the evaluation of VIA-2291's potential impact on inflammation," said Lawrence K. Cohen, Ph.D., chief executive officer of VIA Pharmaceuticals. "Our Phase 2 program, which includes this trial as well as two others, is designed to provide proof-of-concept evidence supporting the potential effectiveness of VIA-2291 and its further development."

The CEA study enrolled 50 patients and is designed to provide direct evaluation of VIA-2291's effect on inflammation by analyzing plaque removed from the carotid arteries of patients treated with VIA-2291 or placebo. CEA is a surgical procedure to remove plaque from the carotid artery to increase blood flow to the brain in patients with significant blockage in the artery to reduce the risk of stroke. Patients in the study are treate
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
2. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
3. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
4. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
5. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
6. Isis Pharmaceuticals Conference Call Notice
7. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
8. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
9. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
10. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
11. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , CHICAGO, Nov. 30 Breast-...e a highly sensitive imaging technique for the det...cult to diagnose breast cancer. BSGI is a molecula...dependent of tissue density and discover very earl...oday at the annual meeting of the Radiological Soc...
(Date:11/30/2009)..., , CHARLESTON, S.C., Nov. 30 /PRNewswir...r Forum, "SEBIO 2009", will be held at the Charles...ston, SC, on December 3-4, 2009. Dr. Cheryl Lilje...ala, patent attorneys with Stipkala LLC, will atte...science companies, investors, scientists, entrepre...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 ...arch report is available in its catalogue: ,, ..., Analysis and Forecasts to 2015 ,, http://ww...ces-Investment-Opportunities-Analysis-and-Forecast...vestment Opportunities, Analysis and Forecasts to ...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 14Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 15Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 16Federal Stimulus Funding Channels More Than 2440 Million to Fred Hutchinson Cancer Research Center 58882 1Federal Stimulus Funding Channels More Than 2440 Million to Fred Hutchinson Cancer Research Center 58882 2Federal Stimulus Funding Channels More Than 2440 Million to Fred Hutchinson Cancer Research Center 58882 3Federal Stimulus Funding Channels More Than 2440 Million to Fred Hutchinson Cancer Research Center 58882 4Empire BlueCross BlueShield to Support 2011 World Police 26amp 3B Fire Games in NYC 58880 1Empire BlueCross BlueShield to Support 2011 World Police 26amp 3B Fire Games in NYC 58880 2AlphaHelix Presents AmpXpress 28TM 29 at the BIOTECHNICA Show 14356 1AlphaHelix Presents AmpXpress 28TM 29 at the BIOTECHNICA Show 14356 2
...lowing was,released by the U.S. Department of Just... Members of the Committee.,Thank you for the oppor... this Committee almost six months ago, I have,beco...dicated professionals,at the Justice Department an...iate that much more deeply their service to our Na...
...orporation,(Nasdaq: DNDN ) today announced that i...e (IDMC) to review in October 2008 the interim ana...s Phase 3 IMPACT (IMmunotherapy,for Prostate Adeno...l trial,of PROVENGE(R) (sipuleucel-T). PROVENGE is...unotherapy for the treatment of advanced prostate,...
Other Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4
(Date:12/1/2009)... of the Journal of Thoracic Oncology sought to d...tients with metastatic lung cancer has improved ov...clinical trials. , Researchers performed an ana...mall cell lung cancer (NSCLC) identified through t...tween 1990 and 2005 to assess the true impact of r...
(Date:12/1/2009)...ase Control (CDC) estimates that 1 in 150 children...rum disorder. These children can learn to cope wit...the new therapeutic PC video game EASe Funhouse Tr...oliday gift idea for a child on the autism spectru...cember 1, 2009 -- The new therapeutic PC game EAS...
(Date:12/1/2009)...PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI )...e-Through Motion and Low Perfusion pulse oximetry,...ation -- Masimo Rainbow SET Acoustic Monitoring(TM...ation rate (RRa(TM)) that is accurate, easy-to-use... SET Acoustic Monitoring may enable earlier detect...
(Date:12/1/2009)...ourth-year medical student at Ross University Scho...dicine to help fulfill an unmet need. , ...r 1, 2009 -- Having distinguished himself with hig... Craig Moskowitz--a fourth-year medical student at... go into any area of medicine that he chose. , , ,...
(Date:12/1/2009)...D was elected to the Stemedica Cell Technologies, ...at the Company’s November 20th Board Meeting...009 -- Anthony M. Marlon, MD was elected to the S...a”) Board of Directors at the Company’... Executive Chairman for Stemedica made the announc...
Breaking Medicine News(10 mins):Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 2Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 3Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 2Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 3Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 5Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 6Health News:Trending Against the Norm: How One Top Scoring Ross University Medical Student is Choosing to Make a Difference in Internal Medicine 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3
...ice (ARS) scientists David Ingram and Patricia Mil...in growing compost tea.// Composting usually produ...research has found that adding solubles like solub...ce, formed by the National Organic Standards Board...
...ary product after tests found that it contained ac...he active pharmaceutical// ingredient in Viagra. T...unction and it is expected that acetildenafil has ... suddenly. The FDA said [people with diabetes, hig...
...e theme for the year ‘How young is your heart?’ i...ow a health-friendly regime and be the proud owner...s the foundation to a healthy living. Today’s hect...eatly appealed to the average Indian. But by promo...
...es little doubt about their diligence and ingenuit...ria of success//, growth and development, is unfor...ey purporting to measure the status of Chinese hea...s; Nearly one in three men and one in eight boys...
...oernbecher Children's Hospital, the first clinical...ants to cure Batten disease// is set to get underw...t deadly neurodegenerative disorder. A phase I tri...two different doses will be given to 6 children wi...
... to the tune of one in six often have trouble fall...e alternative medicine or// the other to treat the...lleagues from the National Center for Complementar...n techniques found these therapies helpful for man...
Other Medicine News:Health News:Healthy Heart for a Hearty Life 2Health News:Stem cell trial to beat Batten Disease 2Health News:Stem cell trial to beat Batten Disease 3Health News:Sleeping Problems Often Overcome with Alternative medicine 2
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: